Of note, a just published work—by re-clustering and analyzing a genomic datasets including 196 patients from The Cancer Genome Atlas group—identified a more aggressive subset of HCC patients showing IDH1/2 mutations status and a worse survival than the other subsets [77]. This evidence concerns the gene IDH1 and hepatocellular carcinoma.